FDA
-
-
-
-
-
-
-
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
-
-
-
-
-
-
-
Benitec Biopharma to present BB-301 clinical data at muscular dystrophy conference
-
-
-
-
-
-
-
Benitec's (BNTC) Capital Raise Provides Support For Regulatory Filing - Citizens
-
-
-
-
-
-
-
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society
-
-
-
-
-
-
-
Benitec Biopharma (BNTC) Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301
-
323,977 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

